TNGX Straddle Strategy
TNGX (Tango Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
TNGX (Tango Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $4.16B, a beta of 1.13 versus the broader market, a 52-week range of 6.25-34.39, average daily share volume of 3.7M, a public-listing history dating back to 2020, approximately 137 full-time employees. These structural characteristics shape how TNGX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.13 places TNGX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a straddle on TNGX?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
TNGX snapshot
As of August 14, 2026, spot at $25.40, ATM IV 81.90%, IV rank 16.13%, expected move 23.48%. The straddle on TNGX below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this straddle structure on TNGX specifically: TNGX IV at 81.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a TNGX straddle, with a market-implied 1-standard-deviation move of approximately 23.48% (roughly $5.96 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TNGX expiries trade a higher absolute premium for lower per-day decay. Position sizing on TNGX should anchor to the underlying notional of $25.40 per share and to the trader's directional view on TNGX stock.
TNGX straddle setup
The TNGX straddle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TNGX at $25.40 on that close, the first option leg uses a $25.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TNGX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TNGX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $25.00 | $2.88 |
| Buy 1 | Put | $25.00 | $1.88 |
TNGX straddle risk and reward
- Net Premium / Debit
- -$475.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$472.78
- Breakeven(s)
- $20.25, $29.75
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
TNGX straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on TNGX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$2,024.00 |
| $5.62 | -77.9% | +$1,462.50 |
| $11.24 | -55.7% | +$901.01 |
| $16.85 | -33.6% | +$339.51 |
| $22.47 | -11.5% | -$221.99 |
| $28.08 | +10.6% | -$166.51 |
| $33.70 | +32.7% | +$394.98 |
| $39.31 | +54.8% | +$956.48 |
| $44.93 | +76.9% | +$1,517.98 |
| $50.54 | +99.0% | +$2,079.48 |
When traders use straddle on TNGX
Straddles on TNGX are pure-volatility plays that profit from large moves in either direction; traders typically buy TNGX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
TNGX thesis for this straddle
The market-implied 1-standard-deviation range for TNGX extends from approximately $19.44 on the downside to $31.36 on the upside. A TNGX long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current TNGX IV rank near 16.13% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TNGX at 81.90%. As a Healthcare name, TNGX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TNGX-specific events.
TNGX straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TNGX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TNGX alongside the broader basket even when TNGX-specific fundamentals are unchanged. Always rebuild the position from current TNGX chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on TNGX?
- A straddle on TNGX is the straddle strategy applied to TNGX (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With TNGX stock at $25.40 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed TNGX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are TNGX straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the TNGX straddle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 81.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$472.78 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TNGX straddle?
- The breakeven for the TNGX straddle priced on this page is roughly $20.25 and $29.75 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The TNGX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 23.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on TNGX?
- Straddles on TNGX are pure-volatility plays that profit from large moves in either direction; traders typically buy TNGX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current TNGX implied volatility affect this straddle?
- TNGX ATM IV is at 81.90% with IV rank near 16.13%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.